Depression and back pain often coexist. The exact mechanisms underlying this link aren’t fully understood but experts ...

The approval makes Vraylar (cariprazine) the " first and only" dopamine and serotonin partial agonist indicated as an add-on therapy for depression, according to AbbVie, adding to the lengthening ...

10 The presumed efficacy of some dopamine agonist drugs for improving depression, however, awaits definitive evidence.

New research out of Michigan State University expands on current understanding of the brain chemical dopamine, finding that ...

Opens in a new tab or window Older adults with type 2 diabetes newly treated with a GLP-1 receptor agonist had a lower risk for depression than DPP-4 inhibitor users. There was no difference for ...

Dopamine agonists are commonly prescribed to treat ... Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed to treat depression and anxiety. While SSRIs are effective for managing ...

Patients taking dopamine agonists say the drugs have triggered uncontrollable impulses, including flashing, sex addiction and even pedophilia — leaving them struggling with feelings of shame and ...

Bromocriptine is a sympatholytic D2-dopamine agonist that has been approved for the treatment of type 2 diabetes. Based on animal and human studies, timed bromocriptine administration within 2 h ...

By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.